Sort
326,823 grants matching “clinical trial”
Emory WIHS CRS - Longitudinal Cohort
$2,494,982Ighovwerha Ofotokun · Emory University · U01 · FY2015 · AI
A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease
$2,494,955Howard Feldman · University Of California, San Diego · R01 · FY2023 · AG
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
$2,494,906Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2023 · CA
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$2,494,558Judith S. Currier · University Of California Los Angeles · UM1 · FY2013 · AI
TMJ Intra-Articular Disorders: Impact on Pain, Functioning and Disability
$2,494,554Eric L Schiffman · University Of Minnesota · U01 · FY2011 · DE
Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study
$2,494,395Harold I Feldman · University Of Pennsylvania · U01 · FY2011 · DK
Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study
$2,494,395Harold I Feldman · University Of Pennsylvania · U01 · FY2012 · DK
CTSA INFRASTRUCTURE FOR PEDIATRIC CLINICAL TRIALS
$2,494,370Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2011 · RR
Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT)
$2,494,326Christopher Barnaby Nelson · University Of Melbourne · U01 · FY2025 · MH
Experimental Therapy for Brain Tumors
$2,494,255David M. Ashley · Duke University · P01 · FY2022 · CA
Trial to Assess Chelation Therapy (TACT)
$2,494,247Gervasio A Lamas · University Of Miami School Of Medicine · U01 · FY2008 · HL
Treatment for Complex Patients: Continuing and Extended Care
$2,494,181Joseph R Guydish · University Of California, San Francisco · P50 · FY2014 · DA
ALZHEIMERS DISEASE RESEARCH CENTER
$2,493,850University Of Washington · P50 · FY2004 · AG
Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimerâs disease pathogenesis in the BEACoN Cohort
$2,493,770Michael A Yassa · University Of California-Irvine · R01 · FY2025 · AG
Deciphering novel protein quality control pathways in the nuclear periphery
$2,493,523Christian Dirk Schlieker · Yale University · DP2 · FY2011 · OD
NOVEL INSIGHTS INTO CEREBRAL ISCHEMIC PATHOPHYSIOLOGY IN HUMANS
$2,492,814Lawrence Latour · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
$2,492,623Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2023 · AI
IMPROVING CORD BLOOD TRANSPLANTATION
$2,492,597Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,492,476Christopher K Glass · University Of California, San Diego · P01 · FY2023 · HL
Cardiovascular CT Clinical Research
$2,492,395Marcus Chen · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Alzheimer's Disease Research Center
$2,492,346University Of California San Diego · P50 · FY2005 · AG
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,492,267David S Stephens · Emory University · UM1 · FY2020 · AI
Toward Safer Gene Therapy for Hemophilia A
$2,492,072Roland W. Herzog · Indiana University Indianapolis · P01 · FY2024 · HL
Meth-OD: A PHASE 2A STUDY OF IXT-M200 IN METHAMPHETAMINE OVERDOSE PATIENTS
$2,492,018Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2020 · DA
Fecal Incontinence Treatment Study (FIT Study)
$2,491,974William E Whitehead · Univ Of North Carolina Chapel Hill · U01 · FY2018 · DK